title: Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors.
abstract: BACKGROUND
  The current study describes the clinicopathologic characteristics of 36 patients with lung carcinoma and human immunodeficiency virus (HIV) infection observed within the Italian Cooperative Group on AIDS and Tumors (GICAT).
  
  
  METHODS
  Patients with lung carcinoma and HIV infection collected by the GICAT between 1986-1998 were evaluated retrospectively. As a control group, the authors analyzed 102 patients age < 60 years with lung carcinoma but without HIV infection who were seen at the CRO, National Cancer Institute, Aviano, Italy between 1995-1996.
  
  
  RESULTS
  Patients with lung carcinoma and HIV infection were younger (38 years vs. 53 years) and previously smoked more cigarettes per day (40 vs. 20) than the control group. The main histologic subtype was adenocarcinoma. TNM Stage III-IV disease was observed in 53% of the patients. The median CD4 cell count was 150/mm(3). The median overall survival was significantly shorter in the patients with HIV compared with the control group (5 months vs. 10 months; P = 0.0001).
  
  
  CONCLUSIONS
  The results of the current study demonstrate that lung carcinoma in the HIV setting affects mainly young individuals with a history of heavy tobacco smoking and a moderately advanced immunodeficiency status. Lung carcinoma is associated with a more adverse outcome in HIV patients and represents the cause of death in the majority of these patients.
authors.affiliation: Division of Medical Oncology A, Aviano Cancer Center, Aviano, Italy.
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
authors.forename: M
authors.initials: M
authors.lastname: Spina
authors.forename: S
authors.initials: S
authors.lastname: Sandri
authors.forename: D
authors.initials: D
authors.lastname: Serraino
authors.forename: C
authors.initials: C
authors.lastname: Gobitti
authors.forename: M
authors.initials: M
authors.lastname: Fasan
authors.forename: A
authors.initials: A
authors.lastname: Sinicco
authors.forename: P
authors.initials: P
authors.lastname: Garavelli
authors.forename: A L
authors.initials: AL
authors.lastname: Ridolfo
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000473:pathology / Q000628:therapy; D000328:Adult; D000367:Age Factors; D018791:CD4 Lymphocyte Count; D002277:Carcinoma / Q000150:complications* / Q000473:pathology / Q000628:therapy; D018287:Carcinoma, Large Cell / Q000150:complications / Q000473:pathology / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000150:complications / Q000473:pathology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000473:pathology / Q000628:therapy; D002423:Cause of Death; D016009:Chi-Square Distribution; D005260:Female; D015658:HIV Infections / Q000145:classification / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012074:Remission Induction; D012189:Retrospective Studies; D012907:Smoking / Q000009:adverse effects; D015996:Survival Rate; D016896:Treatment Outcome